Skip to main content

Table 2 Summary of FMISO TBRs and FDG TNRs

From: Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas

 

FMISO TBR, median (IQR)

FDG TNR, median (IQR)

IDH status (n = 87)

Mutant (n = 21)

1.60 (1.49–1.97)

2.17 (1.50–3.45)

Wildtype (n = 66)

2.52 (1.86–3.21)

2.55 (1.97–4.35)

Histology and subtype

AA (n = 18)

 IDH-mut (n = 7)

1.47 (1.42–1.70)

1.50 (1.23–2.55)

 IDH-wt (n = 11)

1.57 (1.46–1.86)

1.90 (1.54–2.39)

AO (n = 11)

1.60 (1.53–1.80)

2.21 (1.83–3.11)

AA + GBM (n = 76)

 IDH-mut (n = 10)

1.70 (1.44–2.21)

1.76 (1.31–3.62)

 IDH-wt (n = 66)

2.52 (1.86–3.21)

2.55 (1.97–4.35)

GBM (n = 58)

 IDH-mut (n = 3)

2.58 (2.27–2.82)

3.80 (2.59–3.95)

 IDH-wt (n = 55)

2.83 (2.24–3.45)

2.73 (2.10–4.41)

  1. IQR interquartile range